Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Trends Pharmacol Sci. 2009 Mar;30(3):105-11. doi: 10.1016/j.tips.2008.11.006. Epub 2009 Feb 9.

RGS9-2: probing an intracellular modulator of behavior as a drug target.

Author information

  • 1Department of Pharmacology and Substance Abuse Research Center, University of Michigan, Ann Arbor, MI 48109, USA.

Abstract

Regulators of G-protein signaling (RGS proteins) comprise a large family of signal transduction molecules that modulate G-protein-coupled-receptor (GPCR) function. Among the RGS proteins expressed in the brain, RGS9-2 is very abundant in the striatum, a brain region involved in movement, motivation, mood and addiction. This protein negatively modulates signal transduction thus playing a key part in striatal function and resultant behavioral responses. In particular, there is evidence of important interactions with mu-opioid- and dopamine D(2)-receptor signaling pathways. Several studies indicate that manipulations of RGS9-2 levels in the striatum might greatly affect pharmacological responses. These findings indicate that treatment strategies targeting RGS9-2 levels or activity might be used to enhance responses to drugs acting at GPCRs and/or prevent undesired drug actions.

PMID:
19211160
[PubMed - indexed for MEDLINE]
PMCID:
PMC3394094
Free PMC Article

Images from this publication.See all images (3)Free text

Figure I
Figure 1
Figure 2
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for Elsevier Science Icon for PubMed Central
    Loading ...
    Write to the Help Desk